Scientific Advisory Board
Our Scientific Advisory Board
Meet the team of scientists and medical experts that help us supercharge our CBD.

The Cannabinoid Expert
Gregor Zorn, Cannaray's Chief Science Officer
Professor of Cannabis Studies
Gregor Zorn is our in-house CBD expert. With his background in biology, nutrition and cannabinoid therapy, he provides the most updated and comprehensive knowledge on CBD and how to use it.

The Pain Experts
Dr Daniela Tonucci, Pain Specialist
MB ChB, DCH, FRCA, FFPMRCA
Dr Benjamin Thomas, Pain Specialist
MBBS FRCA FFPRMCA
Dr Deane Halfpenny, Pain Specialist
MBBCh, FRCS, FFPMRCA
Our resident pain experts, Dr Thomas, Dr Deane Halfpenny and Dr Tonucci, have extensive experience working with medical cannabinoid therapies in the treatment of chronic pain.
Dr. Tonucci's Favourite Product: Bright Days CBD Oil Drops

The Mental Health Expert
Dr Balu Pitchiah, Consultant Psychiatrist
MBBS, MRCPsych, CCST, MBA
You might have spotted Dr. Balu giving advice on our Instagram Live over lockdown. He’s our go-to for all things mental health, with a focus on sleep disorders, anxiety and depression.
Dr. Balu's Favourite Product: Night Time CBD Oil Drops

The Chronic Illness Expert
Dr Andrew Aswani, Anesthesiologist
MB, ChB, MRCP, FRCA, EDIC, FFICM, PhD
Dr. Andrew Aswani is a Consultant in Critical Care Medicine and Anaesthesia at Guy’s and St Thomas’ NHS Foundation Trust and HCA (UK) London Bridge Bridge.
DR. ASWANI’S FAVOURITE PRODUCT: CBD Oil Discovery Kit

The Formula Expert
Dr Peter Laing, Drug Delivery Specialist
BSC, PhD
With a PhD from Bath University, Dr. Laing is a master of drug formulation. That’s why we turn to him for help with our CBD blends. He is an inventor of numerous patents in the fields of small-molecule and biological drugs. He also plays a mean guitar.

The Neurology Expert
Dr David Moorhouse, General Neurologist
MB,BCh, BAO, MRCPI
Dr David Moorhouse is an expert in neurological conditions, with a particular interest in neuropathy and peripherinal nerve injuries. He developed an interest in CBD and medical cannabinoid therapy when his Multiple Sclerosis and Parkinsons patients started to enquire about using the compound.